Loading…
Handelnine Global, LLC dba Navafresh was cited for selling unapproved new drugs including "Dr. Patels Measles Tablets," "Adel-54 Heart Care Drops," "Tri-Origin Ayurveda Diabetic Tablets," and other products without FDA approval, violating sections 505(a) and 301(d) of the FD&C Act. FDA laboratory testing of "Rheumacare Capsules" identified dangerous levels of lead contamination, demonstrating the product was adulterated and failed to meet Current Good Manufacturing Practice (CGMP) requirements. The company's products were also found to be misbranded under section 502 of the FD&C Act. The FDA noted these products posed significant public health concerns due to their unapproved status and safety deficiencies.